Biologics/Biosimilars in Immune and Inflammatory Disease: Will Novel Biologics and Biosimilars Disrupt Competitive Markets?
Topics: Biosimilars, Asthma, Autoimmune, Manufacturing, Packaging & Detailing
|
Disease and Therapy Review: Rheumatoid Arthritis
Topics: Autoimmune, Rheumatology/Arthritis
Regions: Global
|
Competitor Analysis: Interleukin-1 (IL-1) and Receptor (IL-1R) Antagonists
Topics: Autoimmune, Research & Development, Drug Discovery, Rheumatology/Arthritis
|
Systemic Lupus Erythematosus - Pipeline Assessment and Market Forecasts to 2017
Topics: Autoimmune, Drug Discovery
|
Disease and Therapy Review: Fibromyalgia
Topics: Pain, Autoimmune
|
Enlivex Private Vendor Watchlist Profile: Cell Immunotherapy Method for Treating Autoimmune and Inflammatory Conditions
Topics: Biotechnology Company Reports, Emerging Technology, Autoimmune
|
Psoriasis Drugs
Topics: Autoimmune, Prescription Drugs
|
Competitor Analysis: B7 - CD28/CTLA-4 Pathway
Topics: Autoimmune, Drug Discovery, Oncology/Hematology
|
Autoimmune And Inflammation Autoimmune Diseases Therapy Area Pipeline Report
Topics: Autoimmune, Drug Discovery
|
Autoimmune And Inflammation Inflammation Therapy Area Pipeline Report
Topics: Autoimmune
|
Autoimmune And Inflammation Rheumatoid Arthritis Therapy Area Pipeline Report
Topics: Autoimmune, Rheumatology/Arthritis
|
Central Nervous System Multiple Sclerosis Therapy Area Pipeline Report
Topics: Autoimmune, Multiple Sclerosis (MS), CNS/Neurology
|
Autoimmune And Inflammation Allergy Therapy Area Pipeline Report
Topics: Autoimmune
|
Autoimmune And Inflammation Arthritis Therapy Area Pipeline Report
Topics: Autoimmune, Rheumatology/Arthritis
|
Autoimmune And Inflammation Transplant Rejection or Transplantation Therapy Area Pipeline Report
Topics: Autoimmune, Blood Supply, Tissue Banking, Transplantation
|
Multiplex Assays: Evolving Technologies, Applications and Future Directions
Topics: Autoimmune, Molecular Assays
|
The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deal Analysis
Topics: Autoimmune, Drug Discovery
|
Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response
Topics: Autoimmune, Drug Discovery
|
Growth Factors (Blood And Tissue) - A World Report
Topics: Proteomics, Tissue Engineering, Autoimmune
|
SPECIAL REPORT: Can Innovation Supplant Convention in Sarcoidosis Treatment?
Topics: Autoimmune, Research & Development
|
Autoimmune Treatment (2009 - 2014)
Topics: Autoimmune, Drug Discovery
|
Disease and Therapy Review: Systemic Lupus Erythematosus
Topics: Autoimmune, Research & Development, Women's Health
Regions: Global
|
Autoimmune Disease Therapeutics
Topics: Autoimmune
|
Dealmaking and Industry Outlook: Autoimmune and Inflammatory Diseases
Topics: Autoimmune, Drug Discovery
|
The 2010-2015 World Outlook for Psoriasis Drugs
Topics: Autoimmune, Dermatology
|
The Pricing and Reimbursement Environment for Immune Disease Therapies
Topics: General Biotechnology, Autoimmune, Insurance & Managed Care
|
Fibromyalgia Market Forecast
Topics: Autoimmune, Women's Health
|
Liver Disease Treatments: The Global Market
Topics: Hepatitis, Autoimmune, Vaccines
Regions: Global
|
Autoimmune Market Forecast to 2014
Topics: Autoimmune, Research & Development, Prescription Drugs
|
The Rheumatoid Arthritis Market Competitive Landscape and Clinical Stage Analysis
Topics: Autoimmune, Rheumatology/Arthritis
|
Immune/Inflammatory Disease: Early-Stage R&D Technologies and Dealmaking
Topics: Autoimmune, Research & Development, Drug Discovery, Allergy/Immunology
|
Stakeholder Opinions: Celiac Disease - Licensing opportunities exist in untapped market
Topics: Autoimmune, Drug Discovery
|
Will Emerging Agents Disrupt the Psoriatic Arthritis Market?
Topics: Arthritis, Autoimmune
|
Ankylosing Spondylitis: How Have Biological Therapies Affected the Market?
Topics: Arthritis, Autoimmune, Drug Discovery
|
The Global Multiple Sclerosis Market 2009-2024
Topics: Autoimmune, Multiple Sclerosis (MS), CNS/Neurology
|
Stakeholder Opinions: Physician perception of biologics in autoimmune disease - Targeted detailing is the key to success
Topics: Autoimmune
|
U.S. Market for Psoriasis Cream and Medication 2009
Topics: Autoimmune, Over-the-Counter Drugs
Regions: United States
|
Multiple Sclerosis Treatment Market: Opportunities for Oral Drugs
Topics: Autoimmune, Multiple Sclerosis (MS), Drug Discovery, CNS/Neurology
|
Therapeutics and Diagnostics for Women's Disorders
Topics: In Vitro Diagnostics, Osteoporosis, Autoimmune, Women's Health, Obstetrics/Gynecology
|
Women's Health: Worldwide Prescription Drug Markets
Topics: Autoimmune, Prescription Drugs, Women's Health, Oncology/Hematology, Obstetrics/Gynecology
Regions: Global
|
Chinese Markets for Autoimmune Drugs
Topics: Autoimmune, Drug Discovery
Regions: China
|
Autoimmune Disease Series: Strategies for Success in the Challenging Sjögren’s Syndrome Market
Topics: Autoimmune
|
Autoimmune Disease Series: Will Biologics Emerge as New Treatments for Reactive Arthritis?
Topics: General Biotechnology, Arthritis, Autoimmune
|
mediKOL Insight: Where next for MS?
Topics: Autoimmune, Multiple Sclerosis (MS), Drug Discovery, CNS/Neurology
|
Stakeholder Insight: Systemic Lupus Erythematosus Imprecise segmentation complicates treatment algorithms
Topics: Autoimmune, Pharmaceuticals, Women's Health
|
Latin American Rheumatoid Arthritis Drugs Market
Topics: Autoimmune, Drug Discovery, Rheumatology/Arthritis
Regions: South America
|
European Autoimmune Disease Diagnostics Market
Topics: Autoimmune
Regions: Europe
|
U.S. Biotechnology - Therapeutic Monoclonal Antibodies Market
Topics: Research & Development, Antibody Technologies, Autoimmune, Blood Supply, Tissue Banking, Transplantation, Cardiovascular
Regions: United States
|
Stakeholder Opinions: Systemic Lupus Erythematosus - Market Set to Enter Era of Biologic Therapies
Topics: Autoimmune, Women's Health
|
What Strategies Will Yield Novel Treatments for Autoimmune Disease?
Topics: Autoimmune
|
